{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:13:56Z","timestamp":1762244036097,"version":"build-2065373602"},"posted":{"date-parts":[[2025,4,21]]},"group-title":"In Review","reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,3,12]]},"abstract":"<title>Abstract<\/title>\n                <p>Ferroptosis is an iron-dependent cell death pathway that involves multiple genes including the transferrin receptor (TFRC\/CD71), glutathione peroxidase 4 (GPX4) and SLC7A11. This study is based on the hypothesis that orphan nuclear receptor 4A1 (NR4A1) and NR4A2 maintain low levels of ferroptosis in triple negative breast cancer (TNBC) cells and that bis-indole derived (CDIM) compounds act as NR4A1\/2 ligands that induce ferroptosis by enhancing CD71 expression. 1,1-Bis(3\u2019-indolyl)-1-(3,5-disubstitutedphenyl)methane (DIM-3,5) analogs were investigated for their cytotoxicity and effects on NR4A1 and NR4A2 regulated genes and induction of ferroptosis by cytotoxicity, western blot and RT-PCR. Several assays also determined enhanced lipoperoxidation, reactive oxygen species and malondialdehyde formation in TNBC cells. Knockdown of NR4A1, NR4A2, Sp1 and Sp4 was carried out by RNA interference. Molecular mechanisms of NR4A1\/2-mediated regulation of CD71 expression were determined using CD71-luciferase promoter constructs, overexpression of Sp1 and chromatin immunoprecipitation (ChIP) assays. Initial studies show that DIM-3,5 act as an inverse NR4A1\/NR4A2 agonist that downregulated the pro-oncogenic responses\/gene products regulated by both receptors in TNBC cells. DIM-3,5 analogs also induced ROS, malondialdehyde and lipoperoxide formation in TNBC cells and this was accompanied by indicators of ferroptosis that include decreased expression of GPX4 and SLC7A11 and induction of CD71. Induction of CD71, an important biomarker of ferroptosis was observed after treatment of TNBC cells with DIM-3,5 analogs, knockdown of NR4A1, NR4A2, Sp1 or Sp4 demonstrating that induction of CD71 was coregulated by both receptors. Moreover, both promoter and ChIP analysis indicated that NR4A1 and NR4A2 acted as ligand-dependent cofactors of Sp1\/4-mediated expression of CD71 in TNBC cells. CD71, a key biomarker of ferroptosis is an NR4A1\/2\/Sp regulated gene that can be directly targeted by DIM-3,5 inverse NR4A1\/2 agonists to induce ferroptosis in TNBC cells.<\/p>","DOI":"10.21203\/rs.3.rs-6214709\/v1","type":"posted-content","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T08:03:57Z","timestamp":1745222637000},"source":"Crossref","is-referenced-by-count":0,"title":["Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 are Endogenous Regulators of CD71 and Their Ligands Induce Ferroptosis in Breast Cancer"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-3060","authenticated-orcid":false,"given":"Stephen","family":"Safe","sequence":"first","affiliation":[{"name":"Texas A&M University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-457X","authenticated-orcid":false,"given":"Arafat Rahman","family":"Oany","sequence":"additional","affiliation":[{"name":"Texas A&M University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srijana","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Texas A&M University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Ning","family":"Tsui","sequence":"additional","affiliation":[{"name":"Texas A&M University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanuel","family":"Hailemariam","sequence":"additional","affiliation":[{"name":"Texas A&M University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Latka","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Landua","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7943-8595","authenticated-orcid":false,"given":"Sandra","family":"Scherer","sequence":"additional","affiliation":[{"name":"University of Utah, Huntsman Cancer Institute and Department of Oncological Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana L","family":"Welm","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lewis","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/me.2010-0015","article-title":"Minireview: Nuclear Hormone Receptor 4A Signaling: Implications for Metabolic Disease","volume":"24","author":"Pearen MA","year":"2010","unstructured":"Pearen MA & Muscat GEO. Minireview: Nuclear Hormone Receptor 4A Signaling: Implications for Metabolic Disease. Molecular Endocrinology 24(10), 1891\u2013903 (2010)","journal-title":"Molecular Endocrinology"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1042\/EBC20210004","article-title":"Nuclear receptor Nur77: its role in chronic inflammatory diseases","volume":"65","author":"Lith Sanne C","year":"2021","unstructured":"Lith Sanne C & de Vries Carlie JM. Nuclear receptor Nur77: its role in chronic inflammatory diseases. Essays in Biochemistry 65(6), 927\u201339 (2021)","journal-title":"Essays in Biochemistry"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/carcin\/bgu157","article-title":"Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin","volume":"35","author":"Wang JR","year":"2014","unstructured":"Wang JR, Gan WJ, Li XM, zhao YY, Li Y, Lu XX, et al. Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin. Carcinogenesis 35(11), 2474\u201384 (2014)","journal-title":"Carcinogenesis"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1038\/ncomms4388","article-title":"Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-\u03b2 signalling","volume":"5","author":"Zhou F","year":"2014","unstructured":"Zhou F, Drabsch Y, Dekker TJA, de Vinuesa AG, Li Y, Hawinkels LJAC, et al. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-\u03b2 signalling. Nature Communications 5(1), 3388 (2014)","journal-title":"Nature Communications"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2016.02.030","article-title":"High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome","volume":"141","author":"Delgado E","year":"2016","unstructured":"Delgado E, Boisen MM, Laskey R, Chen R, Song C, Sallit J, et al. High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome. Gynecologic Oncology 141(2), 348\u201356 (2016)","journal-title":"Gynecologic Oncology"},{"issue":"27","key":"ref6","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1038\/onc.2011.504","article-title":"The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53","volume":"31","author":"Lee S-O","year":"2012","unstructured":"Lee S-O, Andey T, Jin U-H, Kim K, Sachdeva M & Safe S. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53. Oncogene 31(27), 3265\u201376 (2012)","journal-title":"Oncogene"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12964-024-01834-0","article-title":"BTN3A1 expressed in cervical cancer cells promotes V\u03b39V\u03b42 T cells exhaustion through upregulating transcription factors NR4A2\/3 downstream of TCR signaling","volume":"22","author":"Liu J","year":"2024","unstructured":"Liu J, Wu M, Yang Y, Mei X, Wang L, Wang J, et al. BTN3A1 expressed in cervical cancer cells promotes V\u03b39V\u03b42 T cells exhaustion through upregulating transcription factors NR4A2\/3 downstream of TCR signaling. Cell Communication and Signaling 22(1), 459 (2024)","journal-title":"Cell Communication and Signaling"},{"issue":"47","key":"ref8","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.3748\/wjg.v18.i47.6865","article-title":"Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers","volume":"18","author":"Han YF","year":"2012","unstructured":"Han YF & Cao GW. Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers. World Journal of Gastroenterology 18(47), 6865\u201373 (2012)","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.7314\/APJCP.2013.14.3.2023","article-title":"Orphan Nuclear Receptor Nurr1 as a Potential Novel Marker for Progression in Human Prostate Cancer","volume":"14","author":"Wang J","year":"2013","unstructured":"Wang J, Yang J, Zou Y, Huang GL & He ZW. Orphan Nuclear Receptor Nurr1 as a Potential Novel Marker for Progression in Human Prostate Cancer. Asian Pacific Journal of Cancer Prevention 14(3), 2023\u20132028 (2013)","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.7314\/APJCP.2013.14.5.2805","article-title":"High Cytoplasmic Expression of the Orphan Nuclear Receptor NR4A2 Predicts Poor Survival in Nasopharyngeal Carcinoma","volume":"14","author":"Wang J","year":"2013","unstructured":"Wang J, Yang J, Li BB & He ZW. High Cytoplasmic Expression of the Orphan Nuclear Receptor NR4A2 Predicts Poor Survival in Nasopharyngeal Carcinoma. Asian Pacific Journal of Cancer Prevention 14(5), 2805\u20139 (2013)","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"16","key":"ref11","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1016\/j.ejca.2013.06.001","article-title":"Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy","volume":"49","author":"Han Y","year":"2013","unstructured":"Han Y, Cai H, Ma L, Ding Y, Tan X, Liu Y, et al. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy. European Journal of Cancer 49(16), 3420\u201330 (2013)","journal-title":"European Journal of Cancer"},{"issue":"19","key":"ref12","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/cncr.28228","article-title":"Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy","volume":"119","author":"Han Y","year":"2013","unstructured":"Han Y, Cai H, Ma L, Ding Y, Tan X, Chang W, et al. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy. Cancer 119(19), 3436\u201345 (2013)","journal-title":"Cancer"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.62347\/KCPN6689","article-title":"A novel NR4A2-HuR axis promotes pancreatic cancer growth and tumorigenesis that is inhibited by NR4A2 antagonists","volume":"14","author":"Johnson S","year":"2024","unstructured":"Johnson S, Yu Z, Li X, Zarei M, Vaziri-Gohar A, Lee M, et al. A novel NR4A2-HuR axis promotes pancreatic cancer growth and tumorigenesis that is inhibited by NR4A2 antagonists. American Journal of Cancer Research 14(9), 4337\u201352 (2024)","journal-title":"American Journal of Cancer Research"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s10528-022-10216-5","article-title":"A Proposed TUSC7\/miR-211\/Nurr1 ceRNET Might Potentially be Disturbed by a cer-SNP rs2615499 in Breast Cancer","volume":"60","author":"Abdollahzadeh R","year":"2022","unstructured":"Abdollahzadeh R, Azarnezhad A, Paknahad S, Mansoori Y, Pirhoushiaran M, Kanaani K, et al. A Proposed TUSC7\/miR-211\/Nurr1 ceRNET Might Potentially be Disturbed by a cer-SNP rs2615499 in Breast Cancer. Biochemical Genetics 60(6), 2200\u201325 (2022)","journal-title":"Biochemical Genetics"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1541-7786.MCR-20-0707","article-title":"The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer","volume":"19","author":"Safe S","year":"2020","unstructured":"Safe S, Karki K. The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer. Molecular Cancer Research 19(2), 180\u201391 (2020)","journal-title":"Molecular Cancer Research"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1210\/me.2014-1102","article-title":"Diindolylmethane Analogs Bind NR4A1 and Are NR4A1 Antagonists in Colon Cancer Cells","volume":"28","author":"Lee SO","year":"2014","unstructured":"Lee SO, Li X, Hedrick E, Jin UH, Tjalkens RB, Backos DS, et al. Diindolylmethane Analogs Bind NR4A1 and Are NR4A1 Antagonists in Colon Cancer Cells. Molecular Endocrinology 28(10), 1729\u201339 (2014)","journal-title":"Molecular Endocrinology"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/jpet.117.246389","article-title":"The Nurr1 Ligand,1,1-bis(3\u2019-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism","volume":"365","author":"Hammond SL","year":"2018","unstructured":"Hammond SL, Popichak KA, Li X, Hunt LG, Richman EH, Damale PU, et al. The Nurr1 Ligand,1,1-bis(3\u2019-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism. The Journal of Pharmacology and Experimental Therapeutics. 2018;365(3):636\u201351.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/cancers13112682","article-title":"NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth","volume":"13","author":"Karki K","year":"2021","unstructured":"Karki K, Mohankumar K, Schoeller A, Martin G, Shrestha R & Safe S. NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth. Cancers 13(11), 2682 (2021)","journal-title":"Cancers"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/biom14030284","article-title":"Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands","volume":"14","author":"Upadhyay S","year":"2024","unstructured":"Upadhyay S, Hailemariam AE, Mariyam F, Hafiz Z, Martin G, Kothari J, et al. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands. Biomolecules 14(3), 284\u20134 (2024)","journal-title":"Biomolecules"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/0008-5472.CAN-19-2314","article-title":"A Bis-Indole\u2013Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity","volume":"80","author":"Karki K","year":"2020","unstructured":"Karki K, Wright GA, Mohankumar K, Jin UH, Zhang XH & Safe S. A Bis-Indole\u2013Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity. Cancer Research 80(5), 1011\u201323 (2020)","journal-title":"Cancer Research"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-022-00687-1","article-title":"Systemic therapy for early-stage breast cancer: learning from the past to build the future","volume":"19","author":"Agostinetto E","year":"2022","unstructured":"Agostinetto E, Gligorov J & Piccart M. Systemic therapy for early-stage breast cancer: learning from the past to build the future. Nature Reviews Clinical Oncology 19, 763\u201374 (2022)","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.22.02572","article-title":"Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer","volume":"41","author":"Liedtke C","year":"2023","unstructured":"Liedtke C, Mazouni C, Hess KR, Andr\u00e9 F, Tordai A, Mejia JA, et al. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer. Journal of Clinical Oncology 41(10), 1809\u201315 (2023)","journal-title":"Journal of Clinical Oncology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"107992","DOI":"10.1016\/j.pharmthera.2021.107992","article-title":"Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression","volume":"232","author":"Sui S","year":"2021","unstructured":"Sui S, Xu S & Pang D. Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression. Pharmacology & Therapeutics 232, 107992 (2021)","journal-title":"Pharmacology & Therapeutics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"101017","DOI":"10.1016\/j.neo.2024.101017","article-title":"Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance","volume":"55","author":"Fu B","year":"2024","unstructured":"Fu B, Lou Y, Wu P, Lu X & Xu C. Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance. Neoplasia 55, 101017 (2024)","journal-title":"Neoplasia"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-024-07387-7","article-title":"Ferroptosis as a promising targeted therapy for triple negative breast cancer","volume":"207","author":"Mokhtarpour K","year":"2024","unstructured":"Mokhtarpour K, Razi S & Rezaei N. Ferroptosis as a promising targeted therapy for triple negative breast cancer. Breast Cancer Research and Treatment 207(3), 497\u2013513 (2024)","journal-title":"Breast Cancer Research and Treatment"},{"year":"2022","author":"An S","key":"ref26","unstructured":"An S & Hu M. Quercetin Promotes TFEB Nuclear Translocation and Activates Lysosomal Degradation of Ferritin to Induce Ferroptosis in Breast Cancer Cells. Computational Intelligence and Neuroscience (Print) 2022(1), 5299218 (2022)"},{"key":"ref27","article-title":"Tetrandrine Citrate Suppresses Breast Cancer via Depletion of Glutathione Peroxidase 4 and Activation of Nuclear Receptor Coactivator 4-Mediated Ferritinophagy","volume":"13","author":"Yin J","year":"2022","unstructured":"Yin J, Lin Y, Fang W, Zhang X, Wei J, Hu G, et al. Tetrandrine Citrate Suppresses Breast Cancer via Depletion of Glutathione Peroxidase 4 and Activation of Nuclear Receptor Coactivator 4-Mediated Ferritinophagy. Frontiers in Pharmacology 13 (2022)","journal-title":"Frontiers in Pharmacology"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3390\/life13081730","article-title":"Quercetin and Ferroptosis","volume":"13","author":"Cruz-Gregorio A","year":"2023","unstructured":"Cruz-Gregorio A & Aranda-Rivera AK. Quercetin and Ferroptosis. Life 13(8), 1730\u20130 (2023)","journal-title":"Life"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/nu16081201","article-title":"Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis","volume":"16","author":"Wendlocha D","year":"2024","unstructured":"Wendlocha D, Kubina R, Krzykawski K & Mielczarek-Palacz A. Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis. Nutrients 16(8), 1201 (2024)","journal-title":"Nutrients"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.3390\/ijms24098152","article-title":"Flavone and Hydroxyflavones Are Ligands That Bind the Orphan Nuclear Receptor 4A1 (NR4A1)","volume":"24","author":"Lee M","year":"2023","unstructured":"Lee M, Upadhyay S, Mariyam F, Martin G, Hailemariam A, Lee K, et al. Flavone and Hydroxyflavones Are Ligands That Bind the Orphan Nuclear Receptor 4A1 (NR4A1). International Journal of Molecular Sciences 24(9), 8152\u20132 (2023)","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3390\/ijms23095280","article-title":"Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo","volume":"23","author":"Lee HS","year":"2022","unstructured":"Lee HS, Kim DH, Lee IS, Park JH, Martin G, Safe S, et al. Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo. International Journal of Molecular Sciences 23(9), 5280 (2022)","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s13046-021-02199-9","article-title":"Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth.","volume":"40","author":"Shrestha R","year":"2021","unstructured":"Shrestha R, Mohankumar K, Martin G, Hailemariam A, Lee S, Jin U, et al. Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth. Journal of Experimental & Clinical Cancer Research 40(1), 392 (2021)","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/molpharm.121.000481","article-title":"Resveratrol Binds Nuclear Receptor 4A1 (NR4A1) and Acts as an NR4A1 Antagonist in Lung Cancer Cells","volume":"102","author":"Zhang L","year":"2022","unstructured":"Zhang L, Martin G, Mohankumar K, Hampton JT, Liu WR & Safe S. Resveratrol Binds Nuclear Receptor 4A1 (NR4A1) and Acts as an NR4A1 Antagonist in Lung Cancer Cells. Molecular Pharmacology 102(2), 80\u201391 (2022)","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ijms24010449","article-title":"Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis","volume":"24","author":"Rochette L","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y & Vergely C. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. International Journal of Molecular Sciences 24(1), 449 (2022)","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"ref35","article-title":"Role of oxidative stress-induced ferroptosis in cancer therapy","volume":"28","author":"Li K","year":"2024","unstructured":"Li K, Fan C, Chen J, Xu X, Lu C, Shao H, et al. Role of oxidative stress-induced ferroptosis in cancer therapy. Journal of Cellular and Molecular Medicine 28(10), e18399 (2024)","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin Receptor Is a Specific Ferroptosis Marker","volume":"30","author":"Feng H","year":"2020","unstructured":"Feng H, Schorpp K, Jin J, Yozwiak CE, Hoffstrom BG, Decker AM, et al. Transferrin Receptor Is a Specific Ferroptosis Marker. Cell Reports 30(10), 3411\u20133423.e7 (2020)","journal-title":"Cell Reports"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41419-022-05027-w","article-title":"TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1","volume":"13","author":"Yi L","year":"2022","unstructured":"Yi L, Hu Y, Wu Z, Li Y, Kong M, Kang Z, et al. TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1. Cell Death and Disease 13(7), 592 (2022)","journal-title":"Cell Death and Disease"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1677\/JME-08-0103","article-title":"Non-classical genomic estrogen receptor (ER)\/specificity protein and ER\/activating protein-1 signaling pathways","volume":"41","author":"Safe S","year":"2008","unstructured":"Safe S & Kim K. Non-classical genomic estrogen receptor (ER)\/specificity protein and ER\/activating protein-1 signaling pathways. Journal of Molecular Endocrinology 41(5), 263\u201375 (2008)","journal-title":"Journal of Molecular Endocrinology"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1158\/0008-5472.CAN-16-1546","article-title":"PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1","volume":"77","author":"Lacey A","year":"2017","unstructured":"Lacey A, Rodrigues-Hoffman A & Safe S. PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1. Cancer Research 77(3), 732\u201341 (2017)","journal-title":"Cancer Research"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/mc.22662","article-title":"The nuclear orphan receptor NR4A1 regulates \u03b21-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists","volume":"56","author":"Hedrick E","year":"2017","unstructured":"Hedrick E, Lee S & Safe S. The nuclear orphan receptor NR4A1 regulates \u03b21-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists. Molecular Carcinogenesis 56(9), 2066\u201375 (2017)","journal-title":"Molecular Carcinogenesis"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1535-7163.MCT-20-0474","article-title":"The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells","volume":"20","author":"Shrestha R","year":"2021","unstructured":"Shrestha R, Mohankumar K, Jin U, Martin G & Safe S. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells. Molecular Cancer Therapeutics 20(3), 612\u201322 (2021)","journal-title":"Molecular Cancer Therapeutics"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/MCB.00912-15","article-title":"NR4A1 Antagonists Inhibit \u03b21-Integrin-Dependent Breast Cancer Cell Migration","volume":"36","author":"Hedrick E","year":"2016","unstructured":"Hedrick E, Lee SO, Doddapaneni R, Singh M & Safe S. NR4A1 Antagonists Inhibit \u03b21-Integrin-Dependent Breast Cancer Cell Migration. Molecular and Cellular Biology 36(9), 1383\u201394 (2016)","journal-title":"Molecular and Cellular Biology"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1007\/s00262-023-03530-3","article-title":"Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion","volume":"72","author":"Mohankumar K","year":"2023","unstructured":"Mohankumar K, Wright G, Kumaravel S, Shrestha R, Zhang L, Abdelrahim M, et al. Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion. Cancer Immunology Immunotherapy 72(12), 3985\u201399 (2023)","journal-title":"Cancer Immunology Immunotherapy"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"101807","DOI":"10.1016\/j.redox.2020.101807","article-title":"FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells","volume":"38","author":"Ye Z","year":"2021","unstructured":"Ye Z, Zhuo Q, Hu Q, Xu X, liu M, Zhang Z, et al. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biology 38, 101807 (2021)","journal-title":"Redox Biology"},{"issue":"14","key":"ref45","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell BR","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 185(14), 2401\u201321 (2022)","journal-title":"Cell"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou Q","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal transduction and targeted therapy 9(1), 55 (2024)","journal-title":"Signal transduction and targeted therapy"},{"issue":"33","key":"ref47","doi-asserted-by":"crossref","first-page":"30853","DOI":"10.1074\/jbc.M103339200","article-title":"Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements","volume":"276","author":"Castro-Rivera E","year":"2001","unstructured":"Castro-Rivera E, Samudio I & Safe S. Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements. Journal of Biological Chemistry 276(33), 30853\u201361 (2001)","journal-title":"Journal of Biological Chemistry"},{"issue":"15","key":"ref48","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-12-4081","article-title":"A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models","volume":"73","author":"Zhang X","year":"2013","unstructured":"Zhang X, Claerhout S, Prat A, Dobrolecki LE, Petrovic I, Lai Q, et al. A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models. Cancer Research 73(15), 4885\u201397 (2013)","journal-title":"Cancer Research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-0716-2193-6_10","article-title":"Surgical Procedure for Implantation of Human Tumor Tissue into the Epithelium-Free Mammary Fat Pad of Immunocompromised Mice to Generate Patient-Derived Xenografts (PDX)","volume":"2471","author":"Dobrolecki LE","year":"2022","unstructured":"Dobrolecki LE & Lewis MT. Surgical Procedure for Implantation of Human Tumor Tissue into the Epithelium-Free Mammary Fat Pad of Immunocompromised Mice to Generate Patient-Derived Xenografts (PDX). Methods in molecular biology 2471, 195\u2013207 (2022)","journal-title":"Methods in molecular biology"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen KP","year":"2022","unstructured":"Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nature Cancer 3(2), 232\u201350 (2022)","journal-title":"Nature Cancer"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"102402","DOI":"10.1016\/j.xpro.2023.102402","article-title":"Breast cancer PDxO cultures for drug discovery and functional precision oncology","volume":"4","author":"Scherer SD","year":"2023","unstructured":"Scherer SD, Zhao L, Butterfield AJ, Yang CH, Cortes-Sanchez E, Guillen KP, et al. Breast cancer PDxO cultures for drug discovery and functional precision oncology. STAR Protocols 4(3), 102402 (2023)","journal-title":"STAR Protocols"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ygyno.2019.04.678","article-title":"Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer","volume":"154","author":"Mohankumar K","year":"2019","unstructured":"Mohankumar K, Li X, Sridharan S, Karki K, & Safe S. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer. Gynecologic oncology 154(1), 218\u2013227 (2019)","journal-title":"Gynecologic oncology"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.molpha.2024.100009","article-title":"Dual nuclear receptor 4A1 (NR4A1\/NR4A2) ligands inhibit glioblastoma growth and target TWIST1","volume":"107","author":"Upadhyay S","year":"2025","unstructured":"Upadhyay S, Lee M, Zhang L, Oany AR, Mikheeva SA, Mikheev AM, Rostomily RC & Safe S. Dual nuclear receptor 4A1 (NR4A1\/NR4A2) ligands inhibit glioblastoma growth and target TWIST1. Molecular pharmacology 107(2), 100009 (2025)","journal-title":"Molecular pharmacology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6214709\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6214709\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:10:30Z","timestamp":1762243830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6214709\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":53,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6214709\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41419-025-08143-5","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,4,21]]},"subtype":"preprint"}}